Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 2566 AL 2580

Stem cell-derived extracellular vesicles in the therapeutic intervention of Alzheimer's Disease, Parkinson's Disease, and stroke

Zhou W, Wang X, Dong Y, Gao P, Zhao X, Wang M, Wu X, Shen J, Zhang X, Lu Z, An W.

Theranostics. 2024 May 27;14(8):3358-3384. doi: 10.7150/thno.95953. eCollection 2024.

The Skin-Brain Axis: From UV and Pigmentation to Behaviour Modulation

Ascsillán AA, Kemény LV.

Int J Mol Sci. 2024 Jun 4;25(11):6199. doi: 10.3390/ijms25116199.

Human Endogenous Retroviruses in Neurodegenerative Diseases

Adler GL, Le K, Fu Y, Kim WS.

Genes (Basel). 2024 Jun 5;15(6):745. doi: 10.3390/genes15060745.

Gut Microbes Associated with Neurodegenerative Disorders: A Comprehensive Review of the Literature

Koutsokostas C, Merkouris E, Goulas A, Aidinopoulou K, Sini N, Dimaras T, Tsiptsios D, Mueller C, Nystazaki M, Tsamakis K.

Microorganisms. 2024 Aug 22;12(8):1735. doi: 10.3390/microorganisms12081735.

Orphan GPCRs in Neurodegenerative Disorders: Integrating Structural Biology and Drug Discovery Approaches

Kim J, Choi C.

Curr Issues Mol Biol. 2024 Oct 19;46(10):11646-11664. doi: 10.3390/cimb46100691.

Artificial General Intelligence for the Detection of Neurodegenerative Disorders

Qadri YA, Ahmad K, Kim SW.

Sensors (Basel). 2024 Oct 16;24(20):6658. doi: 10.3390/s24206658.

Neuroprotective properties of zinc oxide nanoparticles: therapeutic implications for Parkinson's disease

Tang KS, See WZC, Naidu R.

Biosci Rep. 2024 Nov 27;44(11):BSR20241102. doi: 10.1042/BSR20241102.

Structures of Oligomeric States of Tau Protein, Amyloid-β, α-Synuclein and Prion Protein Implicated in Alzheimer's Disease, Parkinson's Disease and Prionopathies

Cehlar O, Njemoga S, Horvath M, Cizmazia E, Bednarikova Z, Barrera EE.

Int J Mol Sci. 2024 Dec 4;25(23):13049. doi: 10.3390/ijms252313049.

Cell-Penetrating Peptides: Promising Therapeutics and Drug-Delivery Systems for Neurodegenerative Diseases

Pirhaghi M, Mamashli F, Moosavi-Movahedi F, Arghavani P, Amiri A, Davaeil B, Mohammad-Zaheri M, Mousavi-Jarrahi Z, Sharma D, Langel Ü, Otzen DE, Saboury AA.

Mol Pharm. 2024 May 6;21(5):2097-2117. doi: 10.1021/acs.molpharmaceut.3c01167. Epub 2024 Mar 5.

Leucine-Rich Repeat Kinases

Alessi DR, Pfeffer SR.

Annu Rev Biochem. 2024 Aug;93(1):261-287. doi: 10.1146/annurev-biochem-030122-051144. Epub 2024 Jul 2.

How Parkinson's Disease-Linked LRRK2 Mutations Affect Different CNS Cell Types

Bailey HM, Cookson MR.

J Parkinsons Dis. 2024;14(7):1331-1352. doi: 10.3233/JPD-230432.

Influence of human gut microbiome on the healthy and the neurodegenerative aging

Borrego-Ruiz A, Borrego JJ.

Exp Gerontol. 2024 Sep;194:112497. doi: 10.1016/j.exger.2024.112497. Epub 2024 Jun 27.

Dopamine agonists in the treatment of Parkinson's disease: the show must go on

Jost WH.

J Neural Transm (Vienna). 2024 Dec;131(12):1471-1480. doi: 10.1007/s00702-024-02825-8. Epub 2024 Sep 11.

The Role of α-Synuclein in Etiology of Neurodegenerative Diseases

Krawczuk D, Groblewska M, Mroczko J, Winkel I, Mroczko B.

Int J Mol Sci. 2024 Aug 24;25(17):9197. doi: 10.3390/ijms25179197.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias